Sensor Company Detects 31% Gains

Good Afternoon! 

Hey, everyone. It's Adam from Elite Trade Club. Here’s what moved the market today.

Disruptive Biotech (Sponsored)

Are you looking for a way to potentially boost your returns on Tesla stock?

Look no further than the GraniteShares YieldBoost TSLA ETF (TSYY).

Don't miss out on this opportunity to potentially enhance your Tesla investment.

TSYY offers a unique approach to generating income while maintaining exposure to one of the most talked-about stocks in the market.

Learn More.

Markets 📈

The market made a surprising recovery this afternoon, elevating several U.S. indexes. The Nasdaq Composite moved upward the most, adding half a percent from yesterday’s closing bell.

Market-Moving News 📈

Restaurants

Starbucks Under Pressure as Chinese Rival Targets New York Expansion

Starbucks (NASDAQ: SBUX) faces renewed competitive pressure as Chinese coffee giant Luckin Coffee prepares to enter the U.S. market. The fast-growing brand plans to open its first U.S. location in New York City, offering drinks at nearly half the price of Starbucks.

Luckin’s expansion arrives as Starbucks continues to navigate declining sales. In January, the company reported its fourth straight quarterly dip in revenue, citing reduced customer traffic despite increased investment. In response, Starbucks recently announced plans to lay off over 1,000 employees and streamline its menu to improve efficiency.

While Starbucks works to regain momentum, Luckin is gaining ground. The Chinese brand now operates more than 22,000 stores across China, more than three times the number of Starbucks locations in the country. Founded in 2017, Luckin rebounded from a major accounting scandal in 2020 and has since surged under new leadership.

U.S. consumers may soon see a pricing shift in the coffee market. Luckin intends to sell drinks for as low as $2 to $3 per cup, while Starbucks’ beverages often range from $6 to $7. The aggressive pricing model, paired with an expanding footprint, positions Luckin as a serious challenger.

Starbucks also recently lost its spot as the world’s most valuable restaurant brand, overtaken by McDonald’s. The company now faces dual challenges: increasing internal efficiencies while defending its market share from fast-moving international rivals.

Disruptive Biotech (Sponsored)

Could This Small Biotech Trigger a Major Healthcare Shift?

A little-known biotech is developing a groundbreaking antiviral that may soon change how we fight global viruses—RSV, COVID, Influenza, and more.

With a Phase II trial just around the corner, this company is gaining serious attention for its broad-spectrum approach to viral treatment.

The science is promising, and early investors are positioning ahead of what could be a pivotal announcement.

If successful, this could be one of the most disruptive healthcare breakthroughs in years—and a rare chance to get in before Wall Street catches on.

Click here to get the full story behind this under-the-radar biotech before it breaks out.

Aerospace & Defense

Boeing Secures U.S. Air Force Contract to Build Next-Gen F-47 Fighter Jet

Boeing (NYSE: BA) has been selected to lead the development of the U.S. Air Force’s next-generation fighter jet, officially designated the F-47. The contract marks a significant milestone in the Department of Defense’s plans to modernize its combat aircraft fleet.

Designed as part of the Air Force’s Next Generation Air Dominance (NGAD) program, the F-47 will replace the F-22 Raptor. Equipped with advanced stealth features, it will operate alongside autonomous drone wingmen to deliver enhanced capability in future combat scenarios.

Officials confirmed that experimental jet versions have already flown for hundreds of hours. Flight testing has validated key concepts and technologies shaping the final production model.

Unlike past generations, this aircraft will incorporate a modular design to support rapid upgrades and mission adaptability. Its development will prioritize digital engineering and open-systems architecture to improve lifecycle efficiency.

Boeing secured the NGAD contract after competing with Lockheed Martin, while Northrop Grumman exited the race in 2023. The Air Force expects the F-47 to enter service before the administration leaves office. Progress on the program will continue at Boeing’s advanced aerospace facilities, with further updates anticipated as the jet moves closer to production.

Defense planners see the NGAD initiative as essential to maintaining U.S. air superiority. Boeing’s role in delivering this next-generation system reinforces its position as a key supplier of advanced military aircraft.

Critical Minerals (Sponsored)

This Junior Uranium Stock Could Be Set for a Big Run

Uranium markets are heating up—and billionaire investors like Bill Gates, Jeff Bezos, and Sam Altman are already all-in on the next wave of nuclear energy.

With 90% of America’s uranium imported, the U.S. is in desperate need of domestic and regional supply—and Canada’s uranium-rich regions are front and center.

One small-cap uranium company with assets in the prolific Athabasca Basin and Central Mineral Belt could be in the perfect position. With drilling in progress and rising institutional interest, the setup looks strikingly similar to where UEC was before it soared 2,500%.

If you missed the 2,500% run of UEC, now’s your chance to get in early on what could be the sector’s next breakout.

Get the name and symbol here.

Finance

JPMorgan Exits Key Climate Initiative as Regulatory Pressures Mount

JPMorgan Chase & Co. (NYSE: JPM) has confirmed that its asset management division has exited the Net Zero Asset Managers initiative. This prominent global coalition aligns investment strategies with climate goals. The departure follows a pause in the group's operations earlier this year and reflects changing dynamics in the regulatory and political environment.

By stepping back from the initiative, JPMorgan Asset Management joins a growing list of firms reassessing their participation in global climate coalitions. The Net Zero Asset Managers initiative, launched in 2020, had attracted over 325 signatories managing over $57 trillion in assets at its peak.

Tensions between environmental goals and political scrutiny have intensified in recent months. Several U.S.-based firms have faced criticism from policymakers who question the role of financial institutions in advancing emissions targets. In response, some participants have scaled back their involvement in climate-focused groups.

JPMorgan's decision mirrors a similar move by BlackRock earlier this year, which led to the suspension of Net Zero Asset Managers' coordinated activities. Around the same time, the firm also exited the Net Zero Banking Alliance.

Broader industry conversations continue about how large asset managers balance environmental responsibility with regulatory expectations and client demands. As firms adapt, many choose independent strategies to integrate sustainability into their investment frameworks without formal alliance commitments.

Ouster Inc [OUST] $11.05 (+31.86%)

Ouster makes a strong impression with its Q4 2024 financial report, causing shares to rise.

Regencell Bioscience Holdings [RGC] $58.63 (+30.29%)

Regencell Bioscience continues to fly high following the repurchase program it instituted earlier in the week.

Tonix Pharmaceuticals Holding [TNXP] $23.03 (+26.61%)

Tonix Pharmaceuticals stock saw an uptick after its single-dose Mpox vaccine looks a solid candidate to fight the increase in recent cases.

KinderCare Learning Companies Inc [KLC] $13.76 (-22.08%)

Kindercare stock fell on today’s Q4 earnings report that failed to wow investors.

Outset Medical Inc [OM] $10.05 (-10.90%)

Outset Medical shares crashed back to earth today after hype surrounding its reverse stock split faded away.

Monopar Therapeutics Inc [MNPR] $40.00 (-10.59%)

Monopar Therapeutics dipped despite a promising Wilson disease treatment and excitement from analysts.

Next-Gen Display (Sponsored)

This MicroLED Innovator Could Follow OLED’s 4,090% Path

OLED’s rise from a $6 IPO to a $252 stock created life-changing returns—4,090% to be exact.

Now, all eyes are on the next big shift in display tech: MicroLED.

One low-float company is gaining serious traction, with patented production technology and a major partnership that could fast-track mass commercialization.

With the market expected to surpass $21 billion by 2027, early investors are taking notice.

Get the name and full report now, before this story hits the mainstream.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.

*Standard message/carrier rates may apply.

Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails.